Effects of macrophages in OSCC progression
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 14, 2025
Macrophages
are
crucial
immune
cells
within
the
tumor
microenvironment
(TME),
involved
in
regulating
proliferation,
invasion,
metastasis,
ECM
remodeling,
angiogenesis,
and
immunosuppression.
Although
more
experimental
evidence
clinical
data
indicate
that
macrophages
onset
progression
of
oral
squamous
cell
carcinoma
(OSCC),
exact
pathogenesis
OSCC
associated
with
has
not
been
fully
elucidated.
Enhanced
knowledge
molecular
mechanisms
involving
will
aid
creation
treatments
targeted
specifically
at
macrophages.
This
review
outlines
pro-tumoral
anti-tumoral
effects
OSCC,
emphasizing
interaction
between
It
can
provide
theoretical
basis
for
establishment
complex
regulatory
network
centered
on
explore
novel
therapeutic
strategies
OSCC.
Language: Английский
The regulatory role and mechanism of energy metabolism and immune response in head and neck cancer
Haofan Li,
No information about this author
Peng Qiu,
No information about this author
Linda Oyang
No information about this author
et al.
Genes & Diseases,
Journal Year:
2025,
Volume and Issue:
unknown, P. 101607 - 101607
Published: March 1, 2025
Language: Английский
SOAT1 Activates NLRP3 Inflammasome to Promote Cancer‐Related Lymphangiogenesis and Metastasis via IL‐1β/IL‐1R‐1 Axis in Oral Squamous Cell Carcinoma
Molecular Carcinogenesis,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 26, 2025
Oral
squamous
cell
carcinoma
(OSCC)
is
a
prevalent
type
of
cancer
in
the
head
and
neck
region,
significantly
impacting
patient
survival
rates
quality
life.
Lymph
node
(LN)
metastasis
lead
contributor
to
poor
prognosis
associated
with
OSCC.
SOAT1
plays
critical
role
cholesterol
metabolism
has
been
implicated
various
cancers,
although
its
specific
mechanisms
OSCC
are
poorly
understood.
Additionally,
NLRP3
inflammasome
identified
as
factor
that
promotes
progression
by
influencing
processes
involved
tumor
development,
activation
linked
metastasis.
Lymphangiogenesis
enhancing
OSCC,
while
molecule
networks
regulating
it
remains
unclear.
In
our
study,
we
found
overexpressed
proliferation,
migration,
invasion
cells.
Knockdown
expression
impaired
both
vitro
vivo,
reduced
rate
LN
RNA
sequencing
analysis
revealed
downstream
regulated
SOAT1,
reactivation
having
recovered
malignancy
inhibited
knockdown.
Furthermore,
IL-1β,
released
activation,
could
directly
bind
IL-1R-1
lymphatic
endothelial
cells
(LECs),
enhance
tube
formation
capacity
LECs,
indicating
potential
promoting
lymphangiogenesis
conclusion,
promote
regulate
increase
via
IL-1β/IL-1R-1
axis
Language: Английский
SAR1A Induces Cell Growth and Epithelial–Mesenchymal Transition Through the PI3K/AKT/mTOR Pathway in Head and Neck Squamous Cell Carcinoma: An In Vitro and In Vivo Study
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(11), P. 2477 - 2477
Published: Oct. 28, 2024
Objectives:
Head
and
neck
squamous
cell
carcinoma
(HNSCC)
ranks
sixth
globally,
with
a
50%
five-year
survival
rate.
SAR1A
exhibits
high
expression
levels
in
various
tumor
types,
yet
its
specific
role
HNSCC
remains
to
be
clarified.
Methods:
In
vitro
assays,
such
as
CCK8,
EdU,
colony
formation,
wound-healing,
transwell,
Western
blotting
analyses,
well
vivo
xenografts
lung
metastasis
models,
were
conducted
evaluate
the
impacts
of
on
proliferation,
migration,
invasion.
Transcriptome
sequencing
KEGG
enrichment
pathway
analysis
revealed
evident
alterations
PI3K/AKT/mTOR(PAM)
pathways.
LY294002
(a
PI3K/AKT
inhibitor)
was
used
investigate
PAM
invasion
HNSCC.
Results:
Univariate
multivariate
Cox
regression
screen
gene
prognostic
biomarker
HNSCC,
it
validated
Cancer
Genome
Atlas
(TCGA)
database.
Functional
assays
demonstrated
that
depletion
leads
suppressed
cells.
This
is
accompanied
by
decrease
epithelial–mesenchymal
transition
(EMT)-related
markers
lines.
addition,
diminished
capacities
observed
knockdown
cells
reversed
upon
overexpression
SAR1A.
Furthermore,
RNA-seq
significant
alteration
following
knockdown.
effectively
mitigated
increased
induced
overexpression.
Conclusions:
facilitates
proliferation
EMT
via
PI3K/AKT/mTOR
pathway.
Language: Английский
ETS1 promotes cisplatin resistance of NSCLC cells by promoting GRP78 transcription
Cong Liu,
No information about this author
Junguang Jiang,
No information about this author
Junfang Luo
No information about this author
et al.
Naunyn-Schmiedeberg s Archives of Pharmacology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 9, 2024
Language: Английский
USP8‐mediated PTK7 promotes PIK3CB‐related pathway to accelerate the malignant progression of non‐small cell lung cancer
Wencui Kong,
No information about this author
Xuegang Feng,
No information about this author
Zongyang Yu
No information about this author
et al.
Thoracic Cancer,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 17, 2024
Protein
tyrosine
kinase
7
(PTK7)
has
been
found
to
be
highly
expressed
in
non-small
cell
lung
cancer
(NSCLC),
but
its
specific
molecular
mechanism
needs
further
explored.
Language: Английский